Monsanto Company (MON)

107.00
NYSE
Prev Close 107.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 81.22 / 114.26
Exchange NYSE
Shares Outstanding 437.58B
Market Cap 46.86B
Div & Yield N.A. (N.A)

Latest News

Midday Report: Monsanto Rises on Deal Reports; U.S. Stocks Climb

Midday Report: Monsanto Rises on Deal Reports; U.S. Stocks Climb

Stocks hold onto gains through the morning session as new home sales hit a nearly eight-year high in July.

Stocks Get Lift From Surge in New Home Sales

Stocks Get Lift From Surge in New Home Sales

Stocks hold onto solid gains by mid-morning Tuesday after new home sales hit an eight-year high.

Morning Movers: BBY, TOL, SJM, MON

Morning Movers: BBY, TOL, SJM, MON

U.S. futures were rising across the board on Tuesday while crude prices experienced a decline.

Monsanto (MON) Stock Climbs, Reportedly Nearing Deal with Bayer

Monsanto (MON) Stock Climbs, Reportedly Nearing Deal with Bayer

Monsanto (MON) and suitor Bayer (BAYRY) are said to be moving closer to an agreement as talks advance.

5 Things You Must Know Before the Market Opens Monday

5 Things You Must Know Before the Market Opens Monday

Pfizer finalizes a deal to buy cancer drugmaker Medivation; ChemChina gets U.S. approval for its takeover of Syngenta; Viacom CEO Philippe Dauman is ousted.

ChemChina Receives U.S. Security Clearance for Syngenta Deal

ChemChina Receives U.S. Security Clearance for Syngenta Deal

The two companies are still working with anti-trust regulators on the $44.7 billion deal.

S&P Isn't My Favorite Subject

A breakout is hard to come by.

Monsanto (MON) Stock Down, Giving Bayer Limited Access to Books

Monsanto (MON) Stock Down, Giving Bayer Limited Access to Books

Monsanto (MON) has reportedly given German suitor Bayer (BAYRY) limited access to its books after the U.S. seeds company rejected its sweetened $64 billion takeover bid last month.

Accelerating The Future Of Agriculture: Monsanto Uniquely Positioned To Deliver Integrated Solutions To Drive Long-Term Growth

Accelerating The Future Of Agriculture: Monsanto Uniquely Positioned To Deliver Integrated Solutions To Drive Long-Term Growth

During Monsanto Company's (NYSE: MON) eighth Whistle Stop tour event for investors, chairman and chief executive officer Hugh Grant and other members of the Monsanto executive leadership team will highlight how the...

Monsanto (MON) Stock Rises, Expands Computerized Farming Services

Monsanto (MON) Stock Rises, Expands Computerized Farming Services

Monsanto (MON) plans to broaden its computerized farming subsidiary, which delivers weather and planting advice to farmers.

Twitter, Macy's and J.C. Penney: Doug Kass' Views

Twitter, Macy's and J.C. Penney: Doug Kass' Views

Doug Kass shares his thoughts on his mancrush for Twitter, and why he's buying Macy's.

Monsanto Board Approves Dividend Of 54 Cents Per Share

Monsanto Board Approves Dividend Of 54 Cents Per Share

Monsanto Company (NYSE: MON) announced today that its Board of Directors declared a quarterly dividend on its common stock of 54 cents per share.

Monsanto Company Sets Webcasts For Whistle Stop Investor Tour Event

Monsanto Company Sets Webcasts For Whistle Stop Investor Tour Event

Monsanto Company (NYSE: MON) announced it will hold a webcast in conjunction with its eighth Whistle Stop tour investor event scheduled for Wednesday, August 17 and Thursday, August 18 in St.

Brexit-eers Need To Be 'Swashbuckling' on Trade -- It's Made the U.K. Rich Before

Brexit-eers Need To Be 'Swashbuckling' on Trade -- It's Made the U.K. Rich Before

What's needed after Great Britain's decision to leave the European Union is a bold and daring approach, just like the brave and swashbuckling Brits of yore were famous for.

Monsanto (MON) Stock Up, Bayer Weighs Higher Bid

Monsanto (MON) Stock Up, Bayer Weighs Higher Bid

Monsanto (MON) stock is rising in mid-afternoon trading today as Bayer (BAYRY) is reportedly considering a higher takeover offer for the company.

3 Stocks Dragging The Chemicals Industry Downward

3 Stocks Dragging The Chemicals Industry Downward

TheStreet highlights 3 stocks pushing the chemicals industry lower today.

Bayer's Strong Second-Quarter Figures Make Weak Case for Higher Monsanto Bid

Bayer's Strong Second-Quarter Figures Make Weak Case for Higher Monsanto Bid

Good pharmaceuticals results mask weak crop science results that could be used to justify a new run at Monsanto.

Bayer Quarterly Earnings Top Forecasts as New Drug Sales Steal Limelight

Bayer Quarterly Earnings Top Forecasts as New Drug Sales Steal Limelight

Overall revenue for the Monsanto bidder falls short of expectations.

BASF Quarterly Sales, Profit Miss Forecast

BASF Quarterly Sales, Profit Miss Forecast

The German chemicals company sticks with its forecast for a slight fall in full-year operating profit and a significant decline in sales.

3 Stocks Moving The Chemicals Industry Upward

3 Stocks Moving The Chemicals Industry Upward

TheStreet highlights 3 stocks pushing the chemicals industry higher today.

Monsanto (MON) Stock Up After EU Approves Biotech Soybeans Import

Monsanto (MON) Stock Up After EU Approves Biotech Soybeans Import

Monsanto (MON) stock is reacting favorably to the European Commission's import approval of new genetically modified soybeans for food and livestock feed.

Roundup Ready 2 Xtend Soybeans Gain EU Import Approval

Roundup Ready 2 Xtend Soybeans Gain EU Import Approval

Monsanto Company (NYSE: MON) announced today that the European Commission has granted import approval for Roundup Ready 2 Xtend ® soybeans.

Syngenta Reports 'Constructive' Talks With Regulators as First Half Lags Forecasts

Syngenta Reports 'Constructive' Talks With Regulators as First Half Lags Forecasts

Results from the ChemChina bid target come on the heels of disappointing figures from former suitor Monsanto.

'Mad Money' Lightning Round: Avoid Monsanto Now

'Mad Money' Lightning Round: Avoid Monsanto Now

Cramer says he's frustrated with Synergy Pharmaceuticals' situation.

Jim Cramer's 'Mad Money' Recap: 3 Stocks With Very Different Risks, Rewards

Jim Cramer's 'Mad Money' Recap: 3 Stocks With Very Different Risks, Rewards

The higher the market goes, so, too, will your risks, Cramer says.

Johnson & Johnson Boosts Dow, Netflix Pressures the S&P 500

Johnson & Johnson Boosts Dow, Netflix Pressures the S&P 500

It was the tale of two earnings seasons on Tuesday and Wall Street was stuck in the middle.

Stocks Fluctuate as Johnson & Johnson Climbs, Netflix Shares Tumble

Stocks Fluctuate as Johnson & Johnson Climbs, Netflix Shares Tumble

Stocks fluctuate late Tuesday as earnings reports are mixed.

Trending Tickers: AET, HUM, FCX, BAYRY, MON

Trending Tickers: AET, HUM, FCX, BAYRY, MON

Aetna and Humana each traded down sharply as antitrust hurdles may block $34 billion merger.